The safety and efficacy of sunitinib prior to planned nephrectomy in metastatic clear cell renal cancer

被引：3
|
作者：
Powles, T.
Kayani, I.
Blank, C. U.
Chowdhury, S.
Horenblas, S.
Sarwar, N.
Nathan, P. D.
Boleti, E.
Haanen, J. B.
Bex, A.
机构：
[1] Barts & London Queen Marys Sch Med & Dent, London, England
[2] UCH, London, England
[3] Antoni van Leeuwenhoek Hosp, Netherlands Canc Inst, Amsterdam, Netherlands
[4] Guys & St Thomas Hosp, London SE1 9RT, England
[5] Netherlands Canc Inst, Amsterdam, Netherlands
[6] St Bartholomews Hosp, London, England
[7] Mt Vernon Canc Ctr, Northwood, Middx, England
[8] Royal Free Hosp, London NW3 2QG, England
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2010年 / 28卷 / 15期
关键词：
D O I：
10.1200/jco.2010.28.15_suppl.4603
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4603
引用
收藏
页数：1
相关论文
共 50 条
  • [21] An indirect comparison of the toxicity of sunitinib and pazopanib in metastatic clear cell renal cancer
    Powles, Thomas
    Sarwar, Naveed
    Jones, Rob
    Wilson, Peter
    Boleti, Ekaterini
    Protheroe, Andrew
    Crabb, Simon J.
    Shamash, Jonathan
    Stockdale, Andrew
    Rashid, Sukaina
    Nathan, Paul
    Chowdury, Simon
    EUROPEAN JOURNAL OF CANCER, 2012, 48 (17) : 3171 - 3176
  • [22] Metastatic Renal Cell Carcinoma: Nephrectomy plus Sunitinib versus Sunitinib Alone
    Kroeger, Nils
    Bedke, Jens
    Burchardt, Martin
    AKTUELLE UROLOGIE, 2019, 50 (02) : 132 - 134
  • [23] An Asian subpopulation analysis of the safety and efficacy of sunitinib in metastatic renal cell carcinoma
    Lee, S.
    Chung, H. C.
    Mainwaring, P.
    Ng, C.
    Chang, J. W. C.
    Kwong, P.
    Li, R. K.
    Sriuranpong, V.
    Toh, C. K.
    Lowenthal, S. Pitman
    EJC SUPPLEMENTS, 2009, 7 (02): : 428 - 428
  • [24] Efficacy and safety of sunitinib in patients with metastatic renal cell carcinoma on hemodialysis.
    Casper, J.
    Goebel, D.
    Gruenwald, V.
    Floercken, A.
    Mueller, D.
    Toussaint, K.
    Metzner, B.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [25] Metastatic Renal Cell Cancer Treated With Sunitinib - Toxicity and Efficacy in the Elderly
    Couto, N.
    Sousa, N.
    Begonha, R.
    Oliveira, J.
    Mauricio, J.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S278 - S278
  • [26] Efficacy and safety of dupilumab in a patient with metastatic clear cell renal cell carcinoma
    Ferreira, Cesar
    Freitas, Egidio
    Torres, Tiago
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2024, 52 (11)
  • [27] Meta-analysis of upfront VEGF targeted therapy prior to nephrectomy in metastatic clear cell renal cancer.
    Wimalasingham, Akhila Ganeshi
    Lista, Alfonso Gomez de Liano
    de Bruijn, Roderick
    Haanen, John B. A. G.
    Szabados, Bernadett
    Hall, Peter
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (06)
  • [28] Dynamic epigenetic changes to VHL occur with sunitinib in metastatic clear cell renal cancer
    Stewart, Grant D.
    Powles, Thomas
    Van Neste, Christophe
    Meynert, Alison
    O'Mahony, Fiach
    Laird, Alexander
    Deforce, Dieter
    Van Nieuwerburgh, Filip
    Trooskens, Geert
    Van Criekinge, Wim
    De Meyer, Tim
    Harrison, David J.
    ONCOTARGET, 2016, 7 (18) : 25241 - 25250
  • [29] The effect of sunitinib on biomarkers and tumor heterogeneity in metastatic clear cell renal cancer.
    Stewart, Grant
    Laird, Alexander
    O'Mahony, Fiach
    Eory, Lel
    Lubbock, Alexander
    Nanda, Jyoti
    O'Donnell, Marie
    Mackay, Alan
    Mullen, Peter
    McNeill, Alan
    Riddick, Antony
    Aitchison, Michael
    Berney, Daniel
    Bex, Axel
    Overton, Ian
    Harrison, David James
    Powles, Tom
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (04)
  • [30] Safety of sunitinib in patients with renal cell carcinoma following nephrectomy
    Heraudet, Luc
    Domblides, Charlotte
    Daste, Amaury
    Lefort, Felix
    Bernhard, Jean-Christophe
    Ravaud, Alain
    Gross-Goupil, Marine
    EXPERT OPINION ON DRUG SAFETY, 2020, 19 (07) : 799 - 806
12345